Table 2.

Treatment characteristics within included studies.

Reference	90-Yttrium microsphere	Treatments per patient	Dose (GBq)	Other cancer therapy
Bower and Little	NA	1.04	0.7–2.19a	Chemotherapy at discression of oncologist
Camacho et al.	Resin	NA	NA	All patients post-chemotherapy (refractory)
Camacho et al.	Resin	NA	NA	All patients post-chemotherapy (refractory)
Chaiteerakij et al.	NA	1.55	NA	NA
Hoffmann et al.	Resin	1.03	1.54b	78.8% post-chemotherapy, 36.6% post-surgery
Hyder et al.	NA	NA	NA	27.8% post-chemotherapy. 11.6% post-surgery
Martinez et al.	Resin	NA	NA	NA
Mouli et al.	Glass	2	3.9 Gyb,c	35% post-chemotherapy, 11% post-surgery
Prajapati et al.	Resin	NA	1.68b	All patients post- chemotherapy (refractory)
Saxena et al.	Resin	NA	1.76b	72% post-chemotherapy, 40% post-surgery
Shridhar et al.	Glass	NA	NA	48% post-chemotherapy, 8% post-surgery
Turkmen et al.	Glass and Resin	NA	NA	All patients post-chemotherapy (refractory)

GBq, gigabecquerel; NA, not available; Gy, Grey.

^aRange.

^bMean.

^cRadiation dose reported in Gy, therefore, was not included in weighted analysis.